Overview
Status
Active
Registry date
2021-02-17
Share capital
5,000.00 PLN
Registered address
ul. Adama Mickiewicza 5/7, 60-833 Poznań, Poland
Financials
Revenue history
Filing timeliness
No financial statement for 2024 – the filing deadline has passed. 2 of 3 financial statements were filed late (the longest delay 310 days for 2022).
- 2024not filed
- 202320/05/2024
- 202220/05/2024
- 202109/12/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Grzegorz Rasiak – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 100 | $1,350.62 | 100% |
Beneficial owners
No beneficial owners recorded for the company Asklepios Cure.
Bank accounts
Registered as a VAT taxpayer on 2021-12-22.
No bank accounts reported to the VAT Taxpayer Register.
Debt
3 active proceedings recorded in KRZ.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Feb 10, 2025 | Bankruptcy proceedings for an entrepreneur | In progress | |
| May 10, 2024 | Arrangement approval proceedings | In progress | |
| Jun 10, 2024 | Petition to declare entrepreneur bankruptcy | Closed |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 19, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $48,371$48,371 | BTM Innovations sp. z o.o. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A. | $119,621,017.71 | hasco-lek.pl | ||
| Delpharm PoznańS.A. | $110,900,246.81 | delpharm.com | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| Phytopharm KlękaS.A. | $46,154,888.31 | phytopharm.pl | ||
| Poznańskie Zakłady Zielarskie HerbapolS.A. | $31,668,225.77 | herbapol.poznan.pl | ||
| Curtis Health CapsS.A. | $30,831,117.38 | chc.com.pl | ||
| Przedsiębiorstwo Farmaceutyczne Farmapolsp. z o.o. | $21,462,728.43 | farmapol.pl | ||
| Przedsiębiorstwo Produkcyjno-Handlowe EwaS.A. | $14,322,437.53 | ewa-sa.pl | ||
| STEM Cells SpinS.A. | $287,714.76 | stemcellsspin.com.pl | ||
| BIO Animalisp. z o.o. | $49,176.96 | proanimali.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-03-28 | Name change (Asklepios Cure → Asklepios Cure Spółka Z Ograniczoną Odpowiedzialnością W Upadłości) | |
| 2023-08-23 | Address change (Ul. Franciszka Barcza 58/U18, 10-685, Olsztyn → Ul. Adama Mickiewicza 5/7, 60-833, Poznań) | |
| 2021-02-17 | Entered in the register |
FAQ
The main business activity of Asklepios Cure focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on February 17, 2021.
The headquarters is located at: ul. Adama Mickiewicza 5, 60-833 Poznań.
The management board consists of: Grzegorz Rasiak (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.
Last updated: 2026-10-07